Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

News Release

 View printer-friendly version

Charles River Laboratories Schedules Third-Quarter 2005 Earnings Release and Conference Call

WILMINGTON, Mass., Oct 05, 2005 (BUSINESS WIRE) -- Charles River Laboratories International, Inc. (NYSE:CRL) will release third-quarter 2005 financial results on Thursday, October 27, 2005, after the market closes. A conference call has been scheduled to discuss the results on Friday, October 28, 2005, at 8:30 a.m. E.T.

Investors will have the opportunity to listen to a live webcast of the conference call through the Investor Relations section of the Company's website at ir.criver.com. A replay will be accessible through the website approximately two hours following the conference call and will remain available until Friday, November 4, 2005.

Charles River Laboratories, based in Wilmington, Massachusetts, is a global provider of solutions that advance the drug discovery and development process. Our leading-edge products and services are designed to enable our clients to bring drugs to market faster and more efficiently. Backed by our rigorous, best-in-class procedures and our proven data collection, analysis and reporting capabilities, our products and services are organized into three categories spanning every step of the drug development pipeline: Research Models and Services, Preclinical Services, and Clinical Services. Charles River's customer base includes all of the major pharmaceutical companies and many biotechnology companies, government agencies and leading hospitals and academic institutions. Charles River's 8,000 employees serve clients in more than 50 countries. For more information on Charles River, visit our website at www.criver.com

SOURCE: Charles River Laboratories International, Inc.

Investor Relations Contact:
Susan E. Hardy, 781-262-7616
Director, Investor Relations

Featured Report

2018 Annual Report (PDF)

Investor Hotline

877-567-6CRL (6275)